Integated filing

Lasa Supergenerics' Board approved Q3 FY26 results showing revenue from operations at just Rs 219.93 lakhs, a steep fall from Rs 3,307.99 lakhs in the same quarter last year. The company posted a net loss of Rs 255.47 lakhs for the quarter and Rs 2,992.59 lakhs for the nine months ended December 2025, compared to a profit of Rs 549.39 lakhs and a loss of Rs 46.62 lakhs respectively in the prior-year periods. The collapse follows a May 18, 2025 fire at its main factory (C-4 unit) in Ratnagiri that destroyed uninsured inventories, plant and equipment worth roughly Rs 2,057 lakhs, forcing a complete halt to production. Management has flagged going-concern uncertainty, noting it cannot restart manufacturing and is exploring contract manufacturing or leasing alternatives. The statutory auditor issued a qualified limited review report citing the fire loss, going-concern challenges, dormant bank/FD balances (totaling Rs 39.45 lakhs) where confirmations were not obtained, and a force-majeure customer matter under which revenue recognition is suspended.